STOCK TITAN

Omeros (NASDAQ: OMER) director Leroy Hood granted 15,000 stock options at $10.28

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

OMEROS CORP director Leroy E. Hood received a routine stock option grant as part of non-employee director compensation. He was granted options to buy 15,000 shares of common stock at an exercise price of $10.28 per share, expiring on June 17, 2036. The option will fully vest and become exercisable on the day before the 2027 annual meeting of shareholders, provided he continues to serve as a director through that date.

Positive

  • None.

Negative

  • None.
Insider Hood Leroy E. MD PhD
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 15,000 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 15,000 shares (Direct, null)
Footnotes (1)
  1. Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026. This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.
Option grant size 15,000 shares Stock options to buy common stock granted to director
Exercise price $10.28/share Exercise price for the 15,000-stock option grant
Expiration date June 17, 2036 Expiration of granted stock options if not exercised
Options after grant 15,000 options Total derivative securities following this reported transaction
non-employee director compensation policy financial
"Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting..."
stock option financial
"each non-employee director ... is automatically granted an option to purchase 15,000 shares of common stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of shareholders financial
"the annual stock option award granted ... in conjunction with the annual meeting of shareholders held on June 18, 2026"
A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hood Leroy E. MD PhD

(Last)(First)(Middle)
201 ELLIOTT AVENUE WEST

(Street)
SEATTLE WASHINGTON 98119

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
OMEROS CORP [ OMER ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)(1)$10.2806/18/2026A15,000 (2)06/17/2036Common Stock15,000$015,000D
Explanation of Responses:
1. Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026.
2. This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.
/s/ Peter B. Cancelmo, Attorney-in-Fact06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did OMER (Omeros Corp) director Leroy E. Hood report on this Form 4?

Director Leroy E. Hood reported receiving a stock option grant for 15,000 shares of Omeros common stock. The options were granted at an exercise price of $10.28 per share as part of the company’s non-employee director compensation program.

How many OMER stock options were granted to Leroy E. Hood?

Leroy E. Hood was granted stock options covering 15,000 shares of Omeros common stock. This grant is made automatically under the company’s non-employee director compensation policy in connection with the annual meeting of shareholders.

What is the exercise price of Leroy E. Hood’s new OMER stock options?

The exercise price of the new Omeros stock options granted to Leroy E. Hood is $10.28 per share. This is the price he must pay per share to purchase common stock upon exercising the options in the future.

When do Leroy E. Hood’s OMER stock options vest and become exercisable?

The stock options granted to Leroy E. Hood will fully vest and become exercisable on the day before the 2027 annual meeting of Omeros shareholders, assuming he continues to serve as a director through that date without interruption.

Why did OMER grant 15,000 stock options to Leroy E. Hood?

Omeros granted 15,000 stock options to Leroy E. Hood under its non-employee director compensation policy. Each eligible non-employee director automatically receives an annual option award in conjunction with the company’s annual meeting of shareholders.

When do Leroy E. Hood’s newly granted OMER stock options expire?

Leroy E. Hood’s newly granted Omeros stock options expire on June 17, 2036. After this expiration date, any unexercised portion of the 15,000-share option grant will no longer be exercisable or have value.